Voxmind
Seed
FintechUK · EIS
Raise
£1.5m
Valuation
£6.4m
Runway
21 months
Research Platform
Deal, company, and market research for UK early-stage investors.
33X is a UK early-stage research platform with source-linked evidence, consistent scoring, and financial analysis.
Stress-tested survivabilityCohort benchmarksSource-linked coverage
Built for independent research
- Every claim source-linked
- Deterministic scoring method
- Versioned — full change history
Featured Research
Latest Coverage
Northforge
Pre-Seed
Climate TechUK · SEIS
Raise
£250k
Valuation
£3.1m
Runway
14 months
Lumenpath
Seed+
Health TechUK · EIS
Raise
£2.8m
Valuation
£9.8m
Runway
18 months
How it works
How 33X Works
Step 01
Extract
Source material is ingested and parsed into structured modules — capital terms, team data, traction signals — with each claim tied to its origin document.
Step 02
Stress
Each deal is run through deterministic stress scenarios — burn expansion, revenue miss, timing delay — and benchmarked against stage and sector cohorts.
Step 03
Version
Output is versioned and timestamped. When data changes materially, a new version is released — so the record compounds rather than overwrites.
Access
Membership
Member-funded independent research with full analysis history.
Free
Public summaries and selected market snapshots.
Explore CoverageMember
RecommendedFull deal coverage, score rationale, and structured analysis.
View Membership33X
33X — Independent research. Not investment advice.
33X LABS LTD
Registered in England and Wales
Company No. 17049585
Registered office: 71-75 Shelton Street, London, England, WC2H 9JQ
Regulatory disclaimer
33X Labs Ltd is not authorised or regulated by the Financial Conduct Authority. Content is for informational purposes only and does not constitute investment advice.